| 2008 |
|
 |
| MAY |
Submission of Pre-audit Documents to the USP |
|
| |
 |
| NOV 11-13 |
On-Site Audit on PuraPharm´s manufacturing site |
|
 |
 |
 |
|
| 2009 |
|
 |
| APR 15 |
Completion of the On-Site Audit and relative corrective actions |
|
| |
 |
| APR 22 |
Receipt of the USP´s 1st Observation to PuraPharm´s CMC Documents |
|
| |
 |
| JUN 26 |
Receipt of the USP´s 2nd Observation to PuraPharm´s CMC Documents |
|
| |
 |
| JUL 17 |
Receipt of the USP´s 3rd Observation to PuraPharm´s CMC Documents |
|
| |
 |
| AUG 10 |
Completion of the whole Verification Procedure and receipt of authorization to use the USP Ingredient Verified Mark |
|
 |
 |
 |
| |
* USP verification of traditional Chinese medicine, Coriolus Versicolor Extract, VER Reference#: 1080100301
|